May Measurement Month 2018 : an analysis of blood pressure screening campaign results from Poland
Autor: | Łukasz Skowron, Neil R Poulter, Piotr Hoffman, Xia Xin, Jolanta Malyszko, Agnieszka Olszanecka, Maciej Tomaszewskil, Jacek Jóźwiak, Piotr Jankowski, Dariusz Nowak, Thomas Beaney, Adam Windak, Krzysztof Narkiewicz, Maciej Banach, Mirosław Mastej, Tomasz Tomasik, Agnieszka Motyl, Andrzej Tykarski, Michał Nowicki, Anca Chis Ster |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Diastole Disease 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Internal medicine Diabetes mellitus Control medicine AcademicSubjects/MED00200 Risk factor Systole 1102 Cardiorespiratory Medicine and Haematology business.industry 030229 sport sciences Articles medicine.disease Treatment Blood pressure Cardiovascular System & Hematology Hypertension Screening Disease awareness Alcohol intake Cardiology and Cardiovascular Medicine business Body mass index |
Zdroj: | H111 H108 European Heart Journal Supplements : Journal of the European Society of Cardiology |
Popis: | Hypertension remains the most important cardiovascular risk factor in Poland. May Measurement Month is a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for blood pressure (BP) screening and demonstrating the potential of the opportunistic BP measurements. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in 146 sites in May 2018. Blood pressure was measured in 6450 subjects (mean age: 41 ± 15 years; 59% females). After multiple imputation, the age and sex standardized systolic and diastolic BP was 126.7/78.4 mmHg in the whole analysed group, 132.8/81.3 mmHg in subjects taking antihypertensive drugs, and 125.7/78.0 mmHg in those not taking any antihypertensive drugs. After multiple imputation, the proportions of subjects with high BP (systolic ≥140 mmHg or diastolic ≥90 mmHg or on treatment for raised BP) were 22.2% in the whole analysed group, 39.2% in subjects taking antihypertensive drugs, and 18.6% those not taking any antihypertensive drugs. Overall, hypertension was present in 32.8% of participants, among them 38.7% were not aware of the disease, 53.1% were taking antihypertensive drugs, and 32.3% had BP controlled to target ( |
Databáze: | OpenAIRE |
Externí odkaz: |